The Valley Desk

NCT06712407 · Interventional trial

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Overall registry status Active not recruiting

Phase 4

Conditions IgA Nephropathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov